BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 23123334)

  • 21. Dual role of acetate as a nucleophile and as an internal base in cycloplatination reaction of sym-N,N',N″-triarylguanidines.
    Elumalai P; Thirupathi N; Nethaji M
    Inorg Chem; 2013 Feb; 52(4):1883-94. PubMed ID: 23391250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel cyclometallated Pt(II)-ferrocene complex induces nuclear FOXO3a localization and apoptosis and synergizes with cisplatin to inhibit lung cancer cell proliferation.
    Cortés R; Tarrado-Castellarnau M; Talancón D; López C; Link W; Ruiz D; Centelles JJ; Quirante J; Cascante M
    Metallomics; 2014 Mar; 6(3):622-33. PubMed ID: 24492855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, crystal structures and spectroscopy of meclofenamic acid and its metal complexes with manganese(II), copper(II), zinc(II) and cadmium(II). Antiproliferative and superoxide dismutase activity.
    Kovala-Demertzi D; Staninska M; Garcia-Santos I; Castineiras A; Demertzis MA
    J Inorg Biochem; 2011 Sep; 105(9):1187-95. PubMed ID: 21718655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tuneable reactivity with PPh3 and SnX2 of four- and five-coordinate Pd(II) and Pt(II) complexes containing polyphosphines.
    Fernández-Anca D; García-Seijo MI; García-Fernández ME
    Dalton Trans; 2013 Jul; 42(28):10221-32. PubMed ID: 23728361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
    Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
    J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, characterization, in vitro antitumoral investigations and interaction with plasmid pBR322 DNA of R2eddp-platinum(IV) complexes (R = Et, n-Pr).
    Kaluderović GN; Kommera H; Schwieger S; Paethanom A; Kunze M; Schmidt H; Paschke R; Steinborn D
    Dalton Trans; 2009 Dec; (48):10720-6. PubMed ID: 20023900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tellurium(0) as a ligand: synthesis and characterization of 2-pyridyltellurolates of platinum(II) and structures of [Pt{2-Te-3-(R)C5H3N}2Te(PR'3)] (R = H or Me).
    Chauhan RS; Kedarnath G; Wadawale A; Muñoz-Castro A; Arratia-Perez R; Jain VK; Kaim W
    Inorg Chem; 2010 May; 49(9):4179-85. PubMed ID: 20369824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, reactivity studies, structural aspects, and solution behavior of half sandwich ruthenium(II) N,N',N''-triarylguanidinate complexes.
    Singh T; Kishan R; Nethaji M; Thirupathi N
    Inorg Chem; 2012 Jan; 51(1):157-69. PubMed ID: 22148465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,1-ethylenedithiolato complexes of palladium(II) and platinum(II) with isocyanide and carbene ligands.
    Vicente J; Chicote MT; Huertas S; Jones PG
    Inorg Chem; 2003 Jul; 42(14):4268-74. PubMed ID: 12844298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic studies of substituted titanocene and ansa-titanocene anticancer drugs.
    Gómez-Ruiz S; Kaluderović GN; Prashar S; Polo-Cerón D; Fajardo M; Zizak Z; Sabo TJ; Juranić ZD
    J Inorg Biochem; 2008 Aug; 102(8):1558-70. PubMed ID: 18353439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Template synthesis of iron(II) complexes containing tridentate P-N-S, P-N-P, P-N-N, and tetradentate P-N-N-P ligands.
    Lagaditis PO; Mikhailine AA; Lough AJ; Morris RH
    Inorg Chem; 2010 Feb; 49(3):1094-102. PubMed ID: 20028110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action.
    Egger A; Arion VB; Reisner E; Cebrián-Losantos B; Shova S; Trettenhahn G; Keppler BK
    Inorg Chem; 2005 Jan; 44(1):122-32. PubMed ID: 15627368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structures and cytotoxicity of isopropylamine Pt(II) complexes: a trinuclear squarato-bridged [Pt3(mu2-C4O4)3(H2NPri)6].3H2O and a mononuclear cis-[Pt(NO3)2(H2NPri)2].
    Grabner S; Modec B; Cemazar M; Bukovec N
    J Inorg Biochem; 2005 Jul; 99(7):1465-71. PubMed ID: 15927264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aryl, methyl-diplatinum complexes each with a metal-metal donor-acceptor bond and bridging 2-diphenylphosphinopyridine (PN) ligands: general synthetic approach and mechanism of isomerization.
    Shafaatian B; Akbari A; Nabavizadeh SM; Heinemann FW; Rashidi M
    Dalton Trans; 2007 Nov; (41):4715-25. PubMed ID: 17940654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic copper(II), cobalt(II), zinc(II), and nickel(II) coordination compounds of clotrimazole.
    Betanzos-Lara S; Gómez-Ruiz C; Barrón-Sosa LR; Gracia-Mora I; Flores-Álamo M; Barba-Behrens N
    J Inorg Biochem; 2012 Sep; 114():82-93. PubMed ID: 22717722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A DFT study on the mechanism of a novel, regioselective, intramolecular N-pi rearrangement of cis and trans-eta1-N-Cp*Rh-hydroxytamoxifen complexes to their eta6 derivatives; potential breast cancer pharmaceuticals, and fluorescent probes.
    Efremenko I; Top S; Martin JM; Fish RH
    Dalton Trans; 2009 Jun; (22):4334-43. PubMed ID: 19662311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, cellular uptake and structure-activity relationships for potent cytotoxic trichloridoiridium(III) polypyridyl complexes.
    Scharwitz MA; Ott I; Gust R; Kromm A; Sheldrick WS
    J Inorg Biochem; 2008 Aug; 102(8):1623-30. PubMed ID: 18472166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic and mechanistic pathways of cis and trans-hydroxytamoxifen drug derivatives reacting with Cp*Rh complexes that involve η1-N, η2-N,O, η1-O, and η6 bonding modes, via a novel N-π rearrangement; relative binding affinities and computer docking studies of cis and trans-η6-Cp*Rh-hydroxytamoxifen complexes at the estrogen, ERα and ERβ receptors, and growth inhibition to breast cancer cells.
    Top S; Efremenko I; Rager MN; Vessières A; Yaswen P; Jaouen G; Fish RH
    Inorg Chem; 2011 Jan; 50(1):271-84. PubMed ID: 21121684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
    Bugarcic T; Habtemariam A; Stepankova J; Heringova P; Kasparkova J; Deeth RJ; Johnstone RD; Prescimone A; Parkin A; Parsons S; Brabec V; Sadler PJ
    Inorg Chem; 2008 Dec; 47(24):11470-86. PubMed ID: 19007206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organometallic osmium(II) arene anticancer complexes containing picolinate derivatives.
    van Rijt SH; Peacock AF; Johnstone RD; Parsons S; Sadler PJ
    Inorg Chem; 2009 Feb; 48(4):1753-62. PubMed ID: 19146436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.